Parenteral artemisinins are associated with reduced mortality and neurologic deficits and improved long-term behavioral outcomes in children with severe malaria.

MLA

Conroy, Andrea L., et al. “Parenteral Artemisinins Are Associated with Reduced Mortality and Neurologic Deficits and Improved Long-Term Behavioral Outcomes in Children with Severe Malaria.” BMC Medicine, vol. 19, no. 1, July 2021, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s12916-021-02033-1.

APA

Conroy, A. L., Opoka, R. O., Bangirana, P., Namazzi, R., Okullo, A. E., Georgieff, M. K., Cusick, S., Idro, R., Ssenkusu, J. M., & John, C. C. (2021). Parenteral artemisinins are associated with reduced mortality and neurologic deficits and improved long-term behavioral outcomes in children with severe malaria. BMC Medicine, 19(1), 1–12. https://doi.org/10.1186/s12916-021-02033-1

Chicago

Conroy, Andrea L., Robert O. Opoka, Paul Bangirana, Ruth Namazzi, Allen E. Okullo, Michael K. Georgieff, Sarah Cusick, Richard Idro, John M. Ssenkusu, and Chandy C. John. 2021. “Parenteral Artemisinins Are Associated with Reduced Mortality and Neurologic Deficits and Improved Long-Term Behavioral Outcomes in Children with Severe Malaria.” BMC Medicine 19 (1): 1–12. doi:10.1186/s12916-021-02033-1.